Moreover, in the adenoma patients there was no IL-10 involvement, while this parameter was implicated in the cancer patients' immune responses, suggesting that IL-10 may be prognostic for the passage from adenoma to cancer as a dual biomarker together with sIL-2R (Figures 1, 2, 3, and 6). This evidence concerns the gene IL10 and adenoma.